AstraZeneca’s AZD0780 Shows Significant LDL Reduct...
Category : Clinical Trial Update 3 April 2025Positive results from the PURSUIT phase IIb trial for AstraZeneca’s AZD0780 demonstrated a sta...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Exclusive Licensing Deal: Link Healthcare to Marke...
Category : Licensing/Collaboration Deal 3 April 2025Shionogi & Co., Ltd. is pleased to announce that it has entered into an exclusive licensing agre...
Alnylam Pharma Gains Approval for Qfitlia™ (Fitusi...
Category : Approval/Launch 3 April 2025Alnylam Pharmaceuticals has received approval from the United States Food and Drug Administration (F...
Pfizer’s Abrysvo Wins EU Approval to Protect Adult...
Category : Approval/Launch 2 April 2025Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing...
Akums Unveils Ripasudil+timolol Combo for Glaucoma...
Category : Approval/Launch 2 April 2025Akums Drugs & Pharmaceuticals has announced the launch of a pioneering ripasudil+timolol combina...
Latest Newsletter Post
-
Alnylam Pharma Gains Approval for Q..
3 April 2025
-
Exclusive Licensing Deal: Link Heal..
3 April 2025
-
AstraZeneca’s AZD0780 Shows Signifi..
3 April 2025
-
China NMPA grants breakthrough ther..
2 April 2025
-
Akums Unveils Ripasudil+timolol Com..
2 April 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com